Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2024-12-01 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
嘉事堂药业股份有限公司简式权益变动报告书（中国光大集团股份公司）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of China Everbright Group Co., Ltd. in Jia Shi Tang Pharmaceutical Co., Ltd. The content includes detailed descriptions of share transfers, agreements, shareholding percentages before and after the transaction, and legal compliance statements. It is a formal disclosure of changes in significant share ownership levels, including the nature of the transaction (direct agreement transfer), approvals, and legal references. There is no indication of it being an annual report, earnings release, or other financial report. The document fits the definition of a "Major Shareholding Notification" (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length (7937 characters) and detailed content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2024-12-01 Chinese
关于公司监事长退休离任的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the retirement and departure of the company's Supervisory Board Chairman (监事长). It details the retirement notice, confirms no impact on the board's operation, and expresses gratitude for the individual's service. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to any report publication. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2024-10-25 Chinese
2024年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "嘉事堂药业股份有限公司2024 年第三季度报告" which translates to "Jia Shi Tang Pharmaceutical Co., Ltd. 2024 Third Quarter Report." It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes for the third quarter of 2024. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period ending September 30, 2024. It also mentions that the report is unaudited. The length of the document (13,104 characters) and the detailed financial data confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2024-10-25 Chinese
半年报董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from 嘉事堂药业股份有限公司, detailing the decisions made at the 11th meeting of the 7th Board of Directors held on August 28, 2024. It includes voting results on the 2024 half-year report and departmental restructuring. The document references the half-year report and other announcements published elsewhere but does not contain the report itself or detailed financial data. The document is short (882 characters) and serves as an official announcement of board decisions rather than a full report. Therefore, it fits best under Board/Management Information (MANG).
2024-08-28 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 85% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the first half of 2024, including balances, amounts, and interest details. It is explicitly stated that this summary was approved by the board on August 28, 2024. The content is financial in nature but does not contain a full financial report or comprehensive financial statements. It is a specific financial disclosure related to related party transactions and fund usage, which is typically part of interim or quarterly reporting disclosures. However, the document length is only 2608 characters, which is quite short for a full interim or quarterly report. It also does not appear to be a mere announcement or certification but a substantive financial summary table. Given the nature of the content and the period covered (half-year 2024), this fits best as an Interim / Quarterly Report (IR) type document, as it contains substantive financial data and analysis for a period shorter than a full fiscal year.
2024-08-28 Chinese
半年报财务报表
Interim / Quarterly Report Classification · 100% confidence The document contains detailed consolidated and parent company financial statements including balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2024. The presence of comprehensive financial data for a period shorter than a full fiscal year, including income, expenses, assets, liabilities, and cash flows, indicates this is a substantive interim financial report. There is no indication that this is merely an announcement or a certification. The document length is substantial (15,000 characters), and it includes actual financial statements and analysis for the half-year period. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2024-08-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.